tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Yee, 308 are a BUY (77.78%), 87 are a HOLD (21.97%), 1 are a SELL (0.25%).
Analyst Michael Yee, currently employed at UBS, carries an average stock price target met ratio of 59.24% that have a potential upside of 31.76% achieved within 287 days.
Michael Yee’s has documented 764 price targets and ratings displayed on 50 stocks. The coverage is on Healthcare, Industrials, Pharmaceuticals sectors.
Most recent stock forecast was given on ORKA, Oruka Therapeutics at 01-Jul-2026.
Analyst best performing recommendations are on IMRX (IMMUNEERING CORP).
The best stock recommendation documented was for IMRX (IMMUNEERING CORP) at 6/25/2025. The price target of $3.5 was fulfilled within 2 days with a profit of $0.48 (15.89%) receiving and performance score of 79.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$200
$198.8 (16566.67%)
$3960
5 years 21 days ago
(17-Jun-2021)
0/4 (0%)
$103 (106.19%)
Buy
$100
$98.8 (8233.33%)
$3600
5 years 5 months 25 days ago
(13-Jan-2021)
2/4 (50%)
$-22.4 (-18.30%)
139
Hold
$120
$118.8 (9900.00%)
$2280
6 years 2 months 2 days ago
(06-May-2020)
5/5 (100%)
$16.79 (16.27%)
44
Hold
$120
$118.8 (9900.00%)
$3000
6 years 2 months 2 days ago
(06-May-2020)
6/6 (100%)
$16.79 (16.27%)
45
Sell
$120
$118.8 (9900.00%)
$1200
6 years 8 months 17 days ago
(21-Oct-2019)
7/7 (100%)
$-165.6 (-57.98%)
161
Which stock is Michael Yee is most bullish on?
Which stock is Michael Yee is most reserved on?
What Year was the first public recommendation made by Michael Yee?
